HOME >> MEDICINE >> NEWS
Participation in clinical trials does not appear to affect physician's adherence to guidelines

Physicians who participated in a pharmaceutical-sponsored clinical trial involving asthma medications maintained adherence to treatment guidelines but were more likely to prescribe the sponsor's drugs, according to a study in the June 21 issue of JAMA.

Pharmaceutical companies are frequently involved in clinical trials in general practice, and this may trigger an increase in the use of the sponsoring company's products due to the physicians' experience with these products. This effect may be further strengthened by close physician-company cooperation, which may create physician loyalty toward the company. The effect of participation in company-sponsored studies on drug preferences has not been evaluated in primary care.

Morten Andersen, M.D., Ph.D., of the University of Southern Denmark, Odense, and colleagues investigated the effects of physicians participating in a pharmaceutical company-sponsored clinical trial that was aimed at improving patients' use of asthma medicine. The study compared 10 practices that were conducting the trial on asthma medicine with 165 control (nontrial-conducting) practices in Funen County, Denmark. The study included 5,439 patients treated with asthma drugs from the trial-conducting practices and 59,574 patients from the control practices.

The researchers found that the prevalence of inhaled steroid use among asthma patients increased from 68.5 percent at baseline to 72.9 percent during the second observation year in trial-conducting practices and from 69.1 percent to 73.3 percent in control (nontrial-conducting) practices. There was no impact of participating in the trial on physicians' adherence to international treatment guidelines. Both trial-conducting and control practices had a gradually increased use of the trial sponsor's inhaled corticosteroids, from 74.8 percent to 81.5 percent in trial-conducting practices and from 73.6 percent to 76.6 percent in control practices. Trial-conducting practices were 2
'"/>

Contact: Morten Andersen, M.D., Ph.D.
mandersen@health.sdu.dk
JAMA and Archives Journals
20-Jun-2006


Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
3. International journal group updates guidelines on registration of clinical trials
4. Urgent need for guidance on mobile phone use in clinical care
5. New prostate cancer clinical guidelines to be released
6. First clinical trial of gene therapy for childhood blindness
7. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes
8. Taking the wraps off drug safety data from clinical trials
9. Preclinical results of Geovaxs AIDS vaccines demonstrate potential to protect against disease
10. 30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
11. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process

Post Your Comments:
(Date:4/21/2015)... One of the most difficult aspects ... food cravings. Many diets end badly due to dieters’ ... Some attempt to eat more often throughout the day, ... regular intervals. While this approach does work for many, ... after a meal. For those who are having trouble ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The ... of Science in Health Informatics to answer the ... data into a meaningful, comprehensive wellness profile for ... critical to the development and implementation of health ... administrative, clinical, financial and managerial operations in the ...
(Date:4/21/2015)... April 21, 2015 As nationally ... involved in various components of breast reconstruction research ... , "Breast reconstruction research continues to significantly ... Despite recent advances, many unanswered questions remain requiring ... with optimal results," says Dr. Oscar Ochoa emphasizing ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 CALNOC, the ... Burnes Bolton, DrPH, RN, FAAN, will keynote their upcoming ... in Long Beach, CA on October 26, 2015. ... the American Organization of Nurse Executives (AONE) and the ... president of the American Academy of Nursing and the ...
(Date:4/21/2015)... 2015 Dr. Zain Kadri, a Beverly ... infographic that takes a close look at the rise of ... which appears on both Dr. Kadri’s website and RedOrbit ... in the Age of the Selfie.” According to Dr. Kadri, ... to a variety of A-list patients, the trend of taking ...
Breaking Medicine News(10 mins):Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2
(Date:4/21/2015)... 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: ... of medical devices worldwide, today announced that it will ... Mar 31, 2015 after the U.S. market closes on ... conference call at 8:00 AM on May 12, 2015 ... Beijing/Hong Kong Time). Dial-in details for ...
(Date:4/21/2015)... SAN JOSE, Calif. , April 21, 2015 ... pioneered the use of the iFuse Implant System, ... fusion for certain disorders of the sacroiliac (SI) ... has joined the company,s board of directors effective ... Managing Director for Fidelity Health Insurance Services, LLC.  ...
(Date:4/21/2015)... 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, today announced that the abstract describing long-term ... the Phase 2 clinical trial of the Company,s autologous  ... for an oral presentation at the 2015 American Society ... in Chicago, Illinois May 29 ...
Breaking Medicine Technology:Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 3Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3
Cached News: